Treatment of mice with 2,3,7,8-tetrachlorodibenzo-p-dioxin markedly increases the levels of a number of cytochrome P450 metabolites of omega-3 polyunsaturated fatty acids in the liver and lung

Journal of Toxicological Sciences

Volumn 38, Issue 6, 2013, Pages 833-836

  Yang, Jun ^a   Solaimani, Parrisa ^b,c   Dong, Hua ^a   Hammock, Bruce ^a   Hankinson, Oliver ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AHR; Dioxin; Eicosanoids; Omega 3; Oxylipins; TCDD

Indexed keywords

2, 3, 7, 8 TETRACHLORODIBENZO PARA DIOXIN; CYTOCHROME P450; DOCOSAHEXAENOIC ACID; EPOXIDE; ICOSAPENTAENOIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; OXYLIPIN; PROSTANOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; EXTRACTION; HEART; LETTER; LIVER; LUNG PARENCHYMA; MALE; MASS SPECTROMETRY; METABOLITE; MOUSE; NONHUMAN; SOLID PHASE EXTRACTION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

MUS;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; FATTY ACIDS, OMEGA-3; INJECTIONS, INTRAPERITONEAL; LIVER; LUNG; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; OXYLIPINS; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN;

EID: 84887445958     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.38.833     Document Type: Letter

References (15)

1. Berquin, I.M., Min, Y., Wu, R., Wu, J., Perry, D., Cline, J.M., Thomas, M.J., Thornburg, T., Kulik, G., Smith, A., Edwards, I. J., D'Agostino, R., Zhang, H., Wu, H., Kang, J.X. and Chen, Y. Q. (2007): Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J. Clin. Invest., 117, 1866-1875.
2. Brasky, T.M., Lampe, J.W., Potter, J.D., Patterson, R.E. and White, E. (2010): Specialty supplements and breast cancer risk in the VITamins And Lifestyle (VITAL) Cohort. Cancer Epidemiol. Biomarkers Prev., 19, 1696-1708.
3. Bui, P., Solaimani, P., Wu, X. and Hankinson, O. (2012): 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion. Toxicol. Appl. Pharmacol., 259, 143-151.
4. Denison, M.S., Soshilov, A.A., He, G., DeGroot, D.E. and Zhao, B. (2011): Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol. Sci., 124, 1-22.
5. Fer, M., Dreano, Y., Lucas, D., Corcos, L., Salaun, J. P., Berthou, F. and Amet, Y. (2008): Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450. Arch. Biochem. Biophys., 471, 116-125.
6. Gasiewicz, T.A. and Henry, E.C. (2011): History of Research on the AHR. Hoboken, N.J., Wiley.
7. Hall, M.N., Chavarro, J.E., Lee, I.M., Willett, W.C. and Ma, J. (2008): A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol. Biomarkers. Prev., 17, 1136-1143.
8. Konkel, A. and Schunck, W.H. (2011): Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids. Biochim. Biophys. Acta., 1814, 210-222.
9. Morisseau, C. and Hammock, B.D. (2013): Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health. Annu. Rev. Pharmacol. Toxicol., 53, 37-58.
10. Puga, A. (2011): Perspectives on the potential involvement of the AH receptor-dioxin axis in cardiovascular disease. Toxicol. Sci., 120, 256-261.
11. Rose, D.P. and Connolly, J.M. (1999): Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther., 83, 217-244.
12. Wolk, A., Larsson, S.C., Johansson, J.E. and Ekman, P. (2006): Long-term fatty fish consumption and renal cell carcinoma incidence in women. JAMA, 296, 1371-1376.
13. Yang, J., Schmelzer, K., Georgi, K. and Hammock, B.D. (2009): Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry. Anal. Chem., 81, 8085-8093.
14. Zivkovic, A.M., Yang, J., Georgi, K., Hegedus, C., Nording, M.L., O'Sullivan, A., German, J.B., Hogg, R.J., Weiss, R.H., Bay, C. and Hammock, B.D. (2012): Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations. Metabolomics, 8, 1102-1113.
15. Zhang, G., Panigrahy, D., Mahakian, L.M., Yang, J., Liu, J.Y., Stephen Lee, K.S., Wettersten, H.I., Mlu, A., Hu, X., Tam, S., Hwang, S.H., Ingham, E.S., Kieran, M.W., Weiss, R.H., Ferrara, K.W. and Hammock, B.D. (2013): Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc. Natl. Acad. Sci. USA, 110, 6530-6535.